Magenta Medical vs Pfizer
Side-by-side comparison of AI visibility scores, market position, and capabilities
Magenta Medical is developing the Elevate pLVAD, the world's smallest percutaneous heart pump — FDA Breakthrough Device for HR-PCI and cardiogenic shock; raised $105M Series C in 2023.
About
Magenta Medical is an Israel-based medical device company developing a miniaturized percutaneous Left Ventricular Assist Device (pLVAD) to provide temporary mechanical circulatory support for patients with acute cardiac conditions. Founded and headquartered in Israel, the company''s flagship product, the Elevate™ heart pump, is inserted via an 8-French catheter over a guidewire — making it one of the least invasive cardiac support devices ever developed. It can deliver more than 5 L/min of hemodynamic support.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
About
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
AI Visibility Head-to-Head
Key Details
Also Compare
Magenta Medical vs
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.